The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Non-coding RNAs and potential therapeutic targeting in cancer
Open accessAbstract
Recent advances have begun to clarify the physiological and pathological roles of non-coding RNAs (ncRNAs) in various diseases, including cancer. Among these, microRNAs (miRNAs) have been the most studied and have emerged as key players that are involved in the regulation of important growth regulatory pathways in cancer pathogenesis. The ability of a single ncRNA to modulate the expression of multiple downstream gene targets and associated pathways, have provided a rationale to pursue them for therapeutic drug development in cancer. In this context, early data from pre-clinical studies have demonstrated that synthetic miRNA-based therapeutic molecules, along with various protective coating approaches, has allowed for their efficient delivery and anti-tumor activity. In fact, some of the miRNA-based cancer therapeutic strategies have shown promising results even in early-phase human clinical trials. While the enthusiasm for ncRNA-based cancer therapeutics continue to evolve, the field is still in the midst of unraveling a more precise understanding of the molecular mechanisms and specific downstream therapeutic targets of other lesser studied ncRNAs such as the long-non-coding RNAs, transfer RNAs, circular RNAs, small nucleolar RNAs, and piwi-interacting RNAs. This review article provides the current state of knowledge and the evolving principles for ncRNA-based therapeutic approaches in cancer, and specifically highlights the importance of data to date and the approaches that are being developed to overcome the challenges associated with their delivery and mitigating the off-target effects in human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedRETRACTED ARTICLE: CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7
Zeng, K., Chen, X., Xu, M., Liu, X., Hu, X., Xu, T., Sun, H., Pan, Y., He, B., & Wang, S. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0454-8 · Cited by 628
RetractedPeng, W., Gao, W., & Feng, J. (2014) · Medical Oncology · doi:10.1007/s12032-014-0346-4 · Cited by 144
RetractedDeng, J., Yang, M., Jiang, R., An, N., Wang, T., & Liu, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170860 · Cited by 142
RetractedAn integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931 · cited 1×
“Exosomes—Exosomes were initially discovered three decades ago as cellular fragments attributed as a waste disposal mechanism; however, these small extracellular vehicles are now a topic of active interrogation due to their recognition as important mediators of cellular signalling in cancer [9, 48, 49].”
BackgroundThe landscape of long noncoding RNAs in the human transcriptome
Iyer, M. K., Niknafs, Y. S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T. R., Prensner, J. R., Evans, J. R., Zhao, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3192 · Cited by 2,738
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Sanger, H. L., Klotz, G., Riesner, D., Gross, H. J., & Kleinschmidt, A. K. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3852 · Cited by 2,296
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.040 · Cited by 2,053
Regulation of circRNA biogenesis
Chen, L.-L., & Yang, L. (2015) · RNA Biology · doi:10.1080/15476286.2015.1020271 · Cited by 1,953
Circular RNA: a new star of noncoding RNAs
Qu, S., Yang, X., Li, X., Wang, J., Gao, Y., Shang, R., Sun, W., Dou, K., & Li, H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.003 · Cited by 1,808 · cited 1×
“Although the functional role of circRNAs is evolving each day, several studies have to date demonstrated that circRNAs harbor specific binding sites and primarily act as miRNA sponges or gene regulators [144].”
BackgroundThe EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,699
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A., Minty, A., Chalon, P., Lelias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,637
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Melo, S. A., Sugimoto, H., O’Connell, J. T., Kato, N., Villanueva, A., Vidal, A., Qiu, L., Vitkin, E., Perelman, L. T., Melo, C. A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.005 · Cited by 1,531
Targeting microRNAs in cancer: rationale, strategies and challenges
Garzon, R., Marcucci, G., & Croce, C. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3179 · Cited by 1,493
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Ling, H., Fabbri, M., & Calin, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4140 · Cited by 1,465
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H.-W., Chang, T.-C., Vivekanandan, P., Torbenson, M., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,452
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236 · cited 3×
“miR-34a has multiple tumor suppressor-like features: it forms a positive feedback loop with tumor suppressor TP53; targets several key oncogenes including BCL2, MYC, NOTCH1, CCND1, SNAIL1, and SIRT1 [62, 63]; and functions as a switch to suppress the cancer self-renewal and EMT-inducing transcription factor, Snail [64…”
BackgroundMicroenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
A novel class of small RNAs: tRNA-derived RNA fragments (tRFs)
Lee, Y. S., Shibata, Y., Malhotra, A., & Dutta, A. (2009) · Genes & Development · doi:10.1101/gad.1837609 · Cited by 1,173
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters
Hung, T., Wang, Y., Lin, M. F., Koegel, A. K., Kotake, Y., Grant, G. D., Horlings, H. M., Shah, N., Umbricht, C., Wang, P., et al. (2011) · Nature Genetics · doi:10.1038/ng.848 · Cited by 1,163
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Exfoliation of membrane ecto-enzymes in the form of micro-vesicles
Trams, E. G., Lauter, C. J., Norman Salem, Jr., & Heine, U. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90512-5 · Cited by 1,093
Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M., & Xiong, Y. (2011) · Oncogene · doi:10.1038/onc.2010.568 · Cited by 1,001
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., & Croce, C. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602266103 · Cited by 951
Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement
Goodarzi, H., Liu, X., Nguyen, H. C. B., Zhang, S., Fish, L., & Tavazoie, S. F. (2015) · Cell · doi:10.1016/j.cell.2015.02.053 · Cited by 949
Antisense oligonucleotides: basic concepts and mechanisms.
Dias, N., & Stein, C. A. (2002) · PubMed · Cited by 948
Proteomic profiling of exosomes: Current perspectives
Simpson, R. J., Jensen, S. S., & Lim, J. W. E. (2008) · PROTEOMICS · doi:10.1002/pmic.200800109 · Cited by 857
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Cheng, C. J., Bahal, R., Babar, I. A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D. T., Glazer, P. M., Engelman, D. M., et al. (2015) · Nature · doi:10.1038/nature13905 · Cited by 823
Kiss (2002) · doi:10.1016/s0092-8674(02)00718-3 · Cited by 816
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Jung, G., Hernández-Illán, E., Moreira, L., Balaguer, F., & Goel, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0230-y · Cited by 813
Self-citationEpigenetic silencing of tumour suppressor gene p15 by its antisense RNA
Yu, W., Gius, D., Onyango, P., Muldoon-Jacobs, K., Karp, J., Feinberg, A. P., & Cui, H. (2008) · Nature · doi:10.1038/nature06468 · Cited by 801
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Körner, H., Knyazev, P., Diebold, J., & Hermeking, H. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6533 · Cited by 784
Wang, Y., Xu, Z., Jiang, J., Xu, C., Kang, J., Xiao, L., Wu, M., Xiong, J., Guo, X., & Liu, H. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.03.002 · Cited by 781
MicroRNA sponges: Progress and possibilities
Ebert, M. S., & Sharp, P. A. (2010) · RNA · doi:10.1261/rna.2414110 · Cited by 762
miR-34 – a microRNA replacement therapy is headed to the clinic
Bader, A. G. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00120 · Cited by 728
Xiang, J.-F., Yin, Q.-F., Chen, T., Zhang, Y., Zhang, X.-O., Wu, Z., Zhang, S., Wang, H.-B., Ge, J., Lu, X., et al. (2014) · Cell Research · doi:10.1038/cr.2014.35 · Cited by 726
MEG3 noncoding RNA: a tumor suppressor
Zhou, Y., Zhang, X., & Klibanski, A. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0008 · Cited by 716
Tabernero, J., Shapiro, G. I., LoRusso, P. M., Cervantes, A., Schwartz, G. K., Weiss, G. J., Paz-Ares, L., Cho, D. C., Infante, J. R., Alsina, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0429 · Cited by 698
PDL1 Regulation by p53 via miR-34
Cortez, M. A., Ivan, C., Valdecanas, D., Wang, X., Peltier, H. J., Ye, Y., Araujo, L., Carbone, D. P., Shilo, K., Giri, D. K., et al. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv303 · Cited by 683
Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 667
lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs
Yang, L., Lin, C., Jin, C., Yang, J. C., Tanasa, B., Li, W., Merkurjev, D., Ohgi, K. A., Meng, D., Zhang, J., et al. (2013) · Nature · doi:10.1038/nature12451 · Cited by 657
Kefas, B., Godlewski, J., Comeau, L., Li, Y., Abounader, R., Hawkinson, M., Lee, J., Fine, H., Chiocca, E. A., Lawler, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6639 · Cited by 647
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers
Yan, X., Hu, Z., Feng, Y., Hu, X., Yuan, J., Zhao, S. D., Zhang, Y., Yang, L., Shan, W., He, Q., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.006 · Cited by 643
Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
Non-coding RNAs as regulators of embryogenesis
Pauli, A., Rinn, J. L., & Schier, A. F. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2904 · Cited by 627
Silencing of microRNA families by seed-targeting tiny LNAs
Obad, S., dos Santos, C. O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.786 · Cited by 627
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
Siemens, H., Jackstadt, R., Hünten, S., Kaller, M., Menssen, A., Götz, U., & Hermeking, H. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18552 · Cited by 609
Mathivanan, S., Lim, J. W. E., Tauro, B. J., Ji, H., Moritz, R. L., & Simpson, R. J. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900152-mcp200 · Cited by 591
Stress induces tRNA cleavage by angiogenin in mammalian cells
Fu, H., Feng, J., Liu, Q., Sun, F., Tie, Y., Zhu, J., Xing, R., Sun, Z., & Zheng, X. (2009) · FEBS Letters · doi:10.1016/j.febslet.2008.12.043 · Cited by 571
Luo, M., Li, Z., Wang, W., Zeng, Y., Liu, Z., & Qiu, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.033 · Cited by 549
Zhang, Y., Wang, Z., & Gemeinhart, R. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.015 · Cited by 535
MicroRNAs in the p53 network: micromanagement of tumour suppression
Hermeking, H. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3318 · Cited by 518 · cited 1×
“miRNAs such as the miR-200 family, let-7 family and miR-34a are well-known inhibitors of EMT-inducing transcription factors [80, 81].”
BackgroundNanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 515
Deng, X., Cao, M., Zhang, J., Hu, K., Yin, Z., Zhou, Z., Xiao, X., Yang, Y., Sheng, W., Wu, Y., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.006 · Cited by 511
Lin, R., Maeda, S., Liu, C., Karin, M., & Edgington, T. S. (2007) · Oncogene · doi:10.1038/sj.onc.1209846 · Cited by 510
Reciprocal Regulation of HIF-1α and LincRNA-p21 Modulates the Warburg Effect
Yang, F., Zhang, H., Mei, Y., & Wu, M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.11.004 · Cited by 510
Weng, W., Wei, Q., Toden, S., Yoshida, K., Nagasaka, T., Fujiwara, T., Cai, S., Qin, H., Ma, Y., & Goel, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2541 · Cited by 510
Self-citationMir-34: A New Weapon Against Cancer?
Misso, G., Di Martino, M. T., De Rosa, G., Farooqi, A. A., Lombardi, A., Campani, V., Zarone, M. R., Gullà, A., Tagliaferri, P., Tassone, P., et al. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.47 · Cited by 498
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
Babar, I. A., Cheng, C. J., Booth, C. J., Liang, X., Weidhaas, J. B., Saltzman, W. M., & Slack, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201516109 · Cited by 497
LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer
Bhan, A., & Mandal, S. S. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.07.001 · Cited by 456
Tauro, B. J., Greening, D. W., Mathias, R. A., Mathivanan, S., Ji, H., & Simpson, R. J. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.021303 · Cited by 443
Chemical modification and design of anti-miRNA oligonucleotides
Lennox, K. A., & Behlke, M. A. (2011) · Gene Therapy · doi:10.1038/gt.2011.100 · Cited by 433
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
Xue, X., Yang, Y. A., Zhang, A., Fong, K.-W., Kim, J., Song, B., Li, S., Zhao, J. C., & Yu, J. (2016) · Oncogene · doi:10.1038/onc.2015.340 · Cited by 432
PIWI proteins and PIWI-interacting RNAs in the soma
Ross, R. J., Weiner, M. M., & Lin, H. (2014) · Nature · doi:10.1038/nature12987 · Cited by 427
Fang, Y., Xue, J.-L., Shen, Q., Chen, J., & Tian, L. (2012) · Hepatology · doi:10.1002/hep.25576 · Cited by 425
Gomez, I. G., MacKenna, D. A., Johnson, B. G., Kaimal, V., Roach, A. M., Ren, S., Nakagawa, N., Xin, C., Newitt, R., Pandya, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75852 · Cited by 413
The roles of microRNA in cancer and apoptosis
Lynam‐Lennon, N., Maher, S. G., & Reynolds, J. V. (2009) · Biological Reviews · doi:10.1111/j.1469-185x.2008.00061.x · Cited by 407
Applications of the CRISPR-Cas9 system in cancer biology
Sánchez-Rivera, F. J., & Jacks, T. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3950 · Cited by 405
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Russo, M., Siravegna, G., Blaszkowsky, L. S., Corti, G., Crisafulli, G., Ahronian, L. G., Mussolin, B., Kwak, E. L., Buscarino, M., Lazzari, L., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1283 · Cited by 405
EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
Brabletz, T. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.11.009 · Cited by 403
Tumour angiogenesis regulation by the miR-200 family
Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S., Han, H.-D., Shah, M. Y., Rodriguez-Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 402
Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools
Li, S.-P., Lin, Z.-X., Jiang, X.-Y., & Yu, X.-Y. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.178 · Cited by 390
Polyethylenimine-based intravenous delivery of transgenes to mouse lung
Goula, D., Benoist, C., Mantero, S., Merlo, G., Levi, G., & Demeneix, B. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300717 · Cited by 375
Bramsen, J. B., Laursen, M. B., Nielsen, A. F., Hansen, T. B., Bus, C., Langkjær, N., Babu, B. R., Højland, T., Abramov, M., Van Aerschot, A., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp106 · Cited by 369
Challagundla, K. B., Wise, P. M., Neviani, P., Chava, H., Murtadha, M., Xu, T., Kennedy, R., Ivan, C., Zhang, X., Vannini, I., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv135 · Cited by 359
A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
Bu, P., Chen, K.-Y., Chen, J. H., Wang, L., Walters, J., Shin, Y. J., Goerger, J. P., Sun, J., Witherspoon, M., Rakhilin, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.002 · Cited by 357
Non-coding RNAs: New players in eukaryotic biology
Costa, F. F. (2005) · Gene · doi:10.1016/j.gene.2005.06.019 · Cited by 352
Ying, L., Chen, Q., Wang, Y., Zhou, Z., Huang, Y., & Qiu, F. (2012) · Molecular BioSystems · doi:10.1039/c2mb25070e · Cited by 344
miR-155 : On the Crosstalk Between Inflammation and Cancer
Tili, E., Croce, C. M., & Michaille, J.-J. (2009) · International Reviews of Immunology · doi:10.1080/08830180903093796 · Cited by 340
piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells
Cheng, J., Guo, J.-M., Xiao, B.-X., Miao, Y., Jiang, Z., Zhou, H., & Li, Q.-N. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.05.015 · Cited by 327
MicroRNA-21: A novel therapeutic target in human cancer
Pan, X., Wang, Z.-X., & Wang, R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.12.14252 · Cited by 322
Liu, Z., Sun, M., Lu, K., Liu, J., Zhang, M., Wu, W., De, W., Wang, Z., & Wang, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077293 · Cited by 309
FoxM1: A Master Regulator of Tumor Metastasis
Raychaudhuri, P., & Park, H. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0640 · Cited by 308
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
Okada, N., Lin, C.-P., Ribeiro, M. C., Biton, A., Lai, G., He, X., Bu, P., Vogel, H., Jablons, D. M., Keller, A. C., et al. (2014) · Genes & Development · doi:10.1101/gad.233585.113 · Cited by 297
Baumann, V., & Winkler, J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.116 · Cited by 297
Pramanik, D., Campbell, N. R., Karikari, C., Chivukula, R., Kent, O. A., Mendell, J. T., & Maitra, A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0152 · Cited by 296
Toiyama, Y., Hur, K., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2014) · Annals of Surgery · doi:10.1097/sla.0b013e3182a6909d · Cited by 294
Self-citationCheng, J., Deng, H., Xiao, B., Zhou, H., Zhou, F., Shen, Z., & Guo, J. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.10.004 · Cited by 290
The Coming of Age for Piwi Proteins
Seto, A. G., Kingston, R. E., & Lau, N. C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.021 · Cited by 288
Gee, H. E., Buffa, F. M., Camps, C., Ramachandran, A., Leek, R., Taylor, M., Patil, M., Sheldon, H., Betts, G., Homer, J., et al. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606076 · Cited by 283
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3
Salameh, A., Lee, A. K., Cardó-Vila, M., Nunes, D. N., Efstathiou, E., Staquicini, F. I., Dobroff, A. S., Marchiò, S., Navone, N. M., Hosoya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507882112 · Cited by 277
MicroRNA-7, a Homeobox D10 Target, Inhibits p21-Activated Kinase 1 and Regulates Its Functions
Reddy, S. D. N., Ohshiro, K., Rayala, S. K., & Kumar, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2103 · Cited by 277
lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
Eades, G., Wolfson, B., Zhang, Y., Li, Q., Yao, Y., & Zhou, Q. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0251 · Cited by 271
High turnover rate of transfer RNA in tumor tissue.
Borek, E., Baliga, B. S., Gehrke, C. W., Kuo, C. W., Belman, S., Troll, W., & Waalkes, T. P. (1977) · PubMed · Cited by 265
Wu, H., Liu, B., Chen, Z., Li, G., & Zhang, Z. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2426-z · Cited by 264
Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix
Reshetnyak, Y. K., Andreev, O. A., Lehnert, U., & Engelman, D. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601463103 · Cited by 257
Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis
Mei, Y.-P., Liao, J.-P., Shen, J., Yu, L., Liu, B.-L., Liu, L., Li, R.-Y., Ji, L., Dorsey, S. G., Jiang, Z.-R., et al. (2012) · Oncogene · doi:10.1038/onc.2011.449 · Cited by 256
Graham, L. D., Pedersen, S. K., Brown, G. S., Ho, T., Kassir, Z., Moynihan, A. T., Vizgoft, E. K., Dunne, R., Pimlott, L., Young, G. P., et al. (2011) · Genes & Cancer · doi:10.1177/1947601911431081 · Cited by 256
Long Noncoding RNA, Polycomb, and the Ghosts Haunting INK4b-ARF-INK4a Expression
Aguilo, F., Zhou, M.-M., & Walsh, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4379 · Cited by 255
Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines
Ho, T.-T., Zhou, N., Huang, J., Koirala, P., Xu, M., Fung, R., Wu, F., & Mo, Y.-Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1198 · Cited by 244
The oncofetal H19 RNA connection: Hypoxia, p53 and cancer
Matouk, I. J., Mezan, S., Mizrahi, A., Ohana, P., Abu-lail, R., Fellig, Y., deGroot, N., Galun, E., & Hochberg, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.010 · Cited by 239
Sticky overhangs enhance siRNA-mediated gene silencing
Bolcato-Bellemin, A.-L., Bonnet, M.-E., Creusat, G., Erbacher, P., & Behr, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707831104 · Cited by 236
Huang, M.-D., Chen, W.-M., Qi, F.-Z., Sun, M., Xu, T.-P., Ma, P., & Shu, Y.-Q. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0431-0 · Cited by 236
Tivnan, A., Orr, W. S., Gubala, V., Nooney, R., Williams, D. E., McDonagh, C., Prenter, S., Harvey, H., Domingo-Fernández, R., Bray, I. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038129 · Cited by 233
Slicing tRNAs to boost functional ncRNA diversity
Gebetsberger, J., & Polacek, N. (2013) · RNA Biology · doi:10.4161/rna.27177 · Cited by 233
Takahashi, K., Yan, I. K., Haga, H., & Patel, T. (2014) · Journal of Cell Science · doi:10.1242/jcs.141069 · Cited by 231
The fundamental role of epigenetics in hematopoietic malignancies
Galm, O., Herman, J. G., & Baylin, S. B. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.01.006 · Cited by 230
JC Bose, R., Uday Kumar, S., Zeng, Y., Afjei, R., Robinson, E., Lau, K., Bermudez, A., Habte, F., Pitteri, S. J., Sinclair, R., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b02587 · Cited by 224
MALAT1 long non-coding RNA in cancer
Yoshimoto, R., Mayeda, A., Yoshida, M., & Nakagawa, S. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.09.012 · Cited by 222
Pádua Alves, C., Fonseca, A. S., Muys, B. R., Barros e Lima Bueno, R., Bürger, M. C., Souza, J. E. S., Valente, V., Zago, M. A., & Silva, W. A. (2013) · Stem Cells · doi:10.1002/stem.1547 · Cited by 218
Targeting miR-21 for the Therapy of Pancreatic Cancer
Sicard, F., Gayral, M., Lulka, H., Buscail, L., & Cordelier, P. (2013) · Molecular Therapy · doi:10.1038/mt.2013.35 · Cited by 217
Okugawa, Y., Toiyama, Y., Hur, K., Toden, S., Saigusa, S., Tanaka, K., Inoue, Y., Mohri, Y., Kusunoki, M., Boland, C. R., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu200 · Cited by 213
Self-citationA combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
Kasinski, A. L., Kelnar, K., Stahlhut, C., Orellana, E., Zhao, J., Shimer, E., Dysart, S., Chen, X., Bader, A. G., & Slack, F. J. (2015) · Oncogene · doi:10.1038/onc.2014.282 · Cited by 210
Du, F., Yu, F., Wang, Y., Hui, Y., Carnevale, K., Fu, M., Lu, H., & Fan, D. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302701 · Cited by 209
PVT1: A Rising Star among Oncogenic Long Noncoding RNAs
Colombo, T., Farina, L., Macino, G., & Paci, P. (2015) · BioMed Research International · doi:10.1155/2015/304208 · Cited by 207
Challenges in CRISPR/CAS9 delivery: potential roles of nonviral vectors
Li, L., He, Z.-Y., Wei, X.-W., Gao, G.-P., & Wei, Y.-Q. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.069 · Cited by 202
Lessons from miR-143/145: the importance of cell-type localization of miRNAs
Kent, O. A., McCall, M. N., Cornish, T. C., & Halushka, M. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku461 · Cited by 200
The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer
Siprashvili, Z., Webster, D. E., Johnston, D., Shenoy, R. M., Ungewickell, A. J., Bhaduri, A., Flockhart, R., Zarnegar, B. J., Che, Y., Meschi, F., et al. (2016) · Nature Genetics · doi:10.1038/ng.3452 · Cited by 194
Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway
Wan, G., Mathur, R., Hu, X., Liu, Y., Zhang, X., Peng, G., & Lu, X. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.02.006 · Cited by 193
Wang, X., Zhang, H., Bai, M., Ning, T., Ge, S., Deng, T., Liu, R., Zhang, L., Ying, G., & Ba, Y. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.01.001 · Cited by 192
Srivastava, A. K., Han, C., Zhao, R., Cui, T., Dai, Y., Mao, C., Zhao, W., Zhang, X., Yu, J., & Wang, Q.-E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421365112 · Cited by 188
Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma
Law, P. T.-Y., Qin, H., Ching, A. K.-K., Lai, K. P., Co, N. N., He, M., Lung, R. W.-M., Chan, A. W.-H., Chan, T.-F., & Wong, N. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.032 · Cited by 186
Wang, S., Zhang, J., Wang, Y., & Chen, M. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.014 · Cited by 186
Zhou, K., Nguyen, L. H., Miller, J. B., Yan, Y., Kos, P., Xiong, H., Li, L., Hao, J., Minnig, J. T., Zhu, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520756113 · Cited by 183
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
Redis, R. S., Sieuwerts, A. M., Look, M. P., Tudoran, O., Ivan, C., Spizzo, R., Zhang, X., de Weerd, V., Shimizu, M., Ling, H., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1292 · Cited by 176
Posttranscriptional Regulation of Gene Expression by Piwi Proteins and piRNAs
Watanabe, T., & Lin, H. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.012 · Cited by 173
Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition
Cheng, J.-T., Wang, L., Wang, H., Tang, F.-R., Cai, W.-Q., Sethi, G., Xin, H.-W., & Ma, Z. (2019) · Cells · doi:10.3390/cells8101178 · Cited by 172
Wei, J., Lv, L., Wan, Y., Cao, Y., Li, G., Lin, H., Zhou, R., Shang, C., Cao, J., He, H., et al. (2015) · Hepatology · doi:10.1002/hep.27660 · Cited by 169
Banerjee, R., Russo, N., Liu, M., Basrur, V., Bellile, E. L., Palanisamy, N., Scanlon, C. S., Tubergen, E. V., Inglehart, R. C., Metwally, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms5527 · Cited by 167
Ma, C., Shi, X., Zhu, Q., Li, Q., Liu, Y., Yao, Y., & Song, Y. (2016) · Tumor Biology · doi:10.1007/s13277-015-4521-9 · Cited by 166
Choudhry, H., Schödel, J., Oikonomopoulos, S., Camps, C., Grampp, S., Harris, A. L., Ratcliffe, P. J., Ragoussis, J., & Mole, D. R. (2014) · EMBO reports · doi:10.1002/embr.201337642 · Cited by 165
Yin, H., Xiong, G., Guo, S., Xu, C., Xu, R., Guo, P., & Shu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.04.018 · Cited by 165
CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis
Wu, J., Jiang, Z., Chen, C., Hu, Q., Fu, Z., Chen, J., Wang, Z., Wang, Q., Li, A., Marks, J. R., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.033 · Cited by 164
Piwis and piwi‐interacting RNAs in the epigenetics of cancer
Siddiqi, S., & Matushansky, I. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23363 · Cited by 162
MicroRNAs and cancer stem cells: the sword and the shield
Sun, X., Jiao, X., Pestell, T. G., Fan, C., Qin, S., Mirabelli, E., Ren, H., & Pestell, R. G. (2014) · Oncogene · doi:10.1038/onc.2013.492 · Cited by 161
Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer
Xue, M., Chen, W., & Li, X. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2042-y · Cited by 160
Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
Nishimura, M., Jung, E.-J., Shah, M. Y., Lu, C., Spizzo, R., Shimizu, M., Han, H. D., Ivan, C., Rossi, S., Zhang, X., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0159 · Cited by 160
Chen, J., Cui, L., Yuan, J., Zhang, Y., & Sang, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.068 · Cited by 160
The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma
Yang, X., Xie, X., Xiao, Y., Xie, R., Hu, C.-J., Tang, B., Li, B., & Yang, S. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.035 · Cited by 153
Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer
Okugawa, Y., Toiyama, Y., Toden, S., Mitoma, H., Nagasaka, T., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2015) · Gut · doi:10.1136/gutjnl-2015-309359 · Cited by 152
Self-citationKristensen, L. S., Ebbesen, K. K., Sokol, M., Jakobsen, T., Korsgaard, U., Eriksen, A. C., Hansen, T. B., Kjems, J., & Hager, H. (2020) · Nature Communications · doi:10.1038/s41467-020-18355-2 · Cited by 146
Patterns of urinary excretion of modified nucleosides.
Gehrke, C. W., Kuo, K. C., Waalkes, T. P., & Borek, E. (1979) · PubMed · Cited by 144
Xue, M., Li, X., Li, Z., & Chen, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-1925-x · Cited by 144
Gaur, S., Wen, Y., Song, J. H., Parikh, N. U., Mangala, L. S., Blessing, A. M., Ivan, C., Wu, S. Y., Varkaris, A. S., Shi, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4971 · Cited by 138
EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination
Gómez-Maldonado, L., Tiana, M., Roche, O., Prado‐Cabrero, A., Jensen, L. D., Fernández‐Barral, A., Guijarro-Muñoz, I., Favaro, E., Moreno‐Bueno, G., Sanz, L., et al. (2014) · Oncogene · doi:10.1038/onc.2014.200 · Cited by 135
The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision
Matouk, I., Halle, D., Raveh, E., Gilon, M., Sorin, V., & Hochberg, A. (2015) · Oncotarget · doi:10.18632/oncotarget.6387 · Cited by 133
Polytarchou, C., Hommes, D. W., Palumbo, T., Hatziapostolou, M., Κουτσιούμπα, Μ., Κούκος, Γ., Jong, A. E. V. D. M., Oikonomopoulos, A., van Deen, W. K., Vorvis, C., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.057 · Cited by 131
Tian, X., & Xu, G. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008653 · Cited by 129
Martino, M. T. D., Campani, V., Misso, G., Cantafio, M. E. G., Gullà, A., Foresta, U., Guzzi, P. H., Castellano, M., Grimaldi, A., Gigantino, V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090005 · Cited by 127
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia
Dorrance, A. M., Neviani, P., Ferenchak, G. J., Huang, X., Nicolet, D., Maharry, K. S., Özer, H. G., Hoellarbauer, P., Khalife, J., Hill, E. B., et al. (2015) · Leukemia · doi:10.1038/leu.2015.139 · Cited by 124
Non-coding RNAs: An emerging player in DNA damage response
Zhang, C., & Peng, G. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.11.003 · Cited by 124
Chromosomal imbalances of primary and metastatic lung adenocarcinomas
Goeze, A., Schlüns, K., Wolf, G., Thäsler, Z., Petersen, S., & Petersen, I. (2001) · The Journal of Pathology · doi:10.1002/path.1009 · Cited by 123
Dirin, M., & Winkler, J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.774366 · Cited by 120
Mithraprabhu, S., Khong, T. T., Ramachandran, M., Chow, A., Klarica, D., Mai, L., Walsh, S. J., Broemeling, D., Marziali, A., Wiggin, M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.366 · Cited by 119
Vandghanooni, S., Eskandani, M., Barar, J., & Omidi, Y. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0205 · Cited by 117
Tanaka, R., Satoh, H., Moriyama, M., Satoh, K., Morishita, Y., Yoshida, S., Watanabe, T., Nakamura, Y., & Mori, S. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00325.x · Cited by 114
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer
Hong, L., Han, Y., Zhang, Y., Zhang, H., Zhao, Q., Wu, K., & Fan, D. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.819853 · Cited by 110
Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer
Tanaka, N., Toyooka, S., Soh, J., Kubo, T., Yamamoto, H., Maki, Y., Muraoka, T., Shien, K., Furukawa, M., Ueno, T., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.10.002 · Cited by 110
Clinical Significance of Long Intergenic Noncoding RNA-p21 in Colorectal Cancer
Zhai, H., Fesler, A. T., Schee, K., Fodstad, Ø., Flatmark, K., & Ju, J. (2013) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2013.06.003 · Cited by 109
miR-155 as a novel clinical target for hematological malignancies
Witten, L., & Slack, F. J. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz183 · Cited by 107
Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy
Deng, R., Shen, N., Yang, Y., Yu, H., Xu, S., Yang, Y.-W., Liu, S., Meguellati, K., & Yan, F. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.013 · Cited by 106
Small molecules targeting microRNA for cancer therapy: Promises and obstacles
Wen, D., Danquah, M. K., Chaudhary, A., & Mahato, R. I. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.011 · Cited by 104
Martino, M. T. D., Gullà, A., Cantafio, M. E. G., Altomare, E., Amodio, N., Leone, E., Morelli, E., Lio, S. G., Caracciolo, D., Rossi, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089659 · Cited by 103
Ahir, M., Upadhyay, P., Ghosh, A., Sarker, S., Bhattacharya, S., Gupta, P., Ghosh, S., Chattopadhyay, S., & Adhikary, A. (2020) · Biomaterials Science · doi:10.1039/d0bm00015a · Cited by 102
Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang, C., Long, H., Yao, K., Chen, J., Zhang, J., & Hu, J. (2015) · Europe PMC (PubMed Central) · Cited by 97
Tan, A., Li, Q., & Chen, L. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.020 · Cited by 97
Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system
Zhao, Y., Dai, Z., Yang, L. H., Yin, M., Ma, K., He, M., Ouyang, H., & Teng, C. (2014) · Scientific Reports · doi:10.1038/srep03943 · Cited by 96
Zhao, Y., Xu, J., Le, V. M., Gong, Q., Li, S., Gao, F., Ni, L., Liu, J., & Liang, X. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00867 · Cited by 94
pHLIP-Mediated Translocation of Membrane-Impermeable Molecules into Cells
Thévenin, D., An, M., & Engelman, D. M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.06.006 · Cited by 93
Xie, Y., Stewart, T. M., Wang, Y., Yu, F., Li, J., Marton, L. J., Casero, R. A., & Oupický, D. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.017 · Cited by 90
The expanding roles of long non-coding RNAs in the regulation of cancer stem cells
Ma, Z., Wang, Y., Xin, H.-W., Wang, L., Arfuso, F., Dharmarajan, A., Kumar, A. P., Wang, H., Tang, F. R., Warrier, S. R., et al. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.003 · Cited by 90
Small nucleolar RNAs functioning and potential roles in cancer
Thorenoor, N., & Slabý, O. (2014) · Tumor Biology · doi:10.1007/s13277-014-2818-8 · Cited by 88
Long non-coding RNA growth arrest-specific transcript 5 in tumor biology
Yu, X., & Li, Z. (2015) · Oncology Letters · doi:10.3892/ol.2015.3553 · Cited by 87
Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers
Tovar-Camargo, O. A., Toden, S., & Goel, A. (2016) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1156535 · Cited by 85
Self-citationDai, Y., Li, D., Chen, X., Tan, X., Gu, J., Chen, M., & Zhang, X. (2018) · Medical Science Monitor · doi:10.12659/msm.908009 · Cited by 85
Zhao, P., Li, M., Wang, Y., Chen, Y., He, C., Zhang, X., Tan, Y., Lu, Y., You, J., Lee, R. J., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.022 · Cited by 83
Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations
Gougèlet, A., Sartor, C., Bachelot, L., Godard, C., Marchiol, C., Renault, G., Torès, F., Nitschké, P., Cavard, C., Terris, B., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308969 · Cited by 82
A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA
Zhang, T., Xue, X., He, D., & Hsieh, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.003 · Cited by 80
A New Lnc in Metastasis: Long Noncoding RNA Mediates the ProMetastatic Functions of TGF-β
Li, W., & Kang, Y. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.014 · Cited by 79
Zhang, Z.-X., Liu, Z., Jiang, B., Lu, X., Ning, X., Yuan, C.-T., & Wang, A. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.158 · Cited by 78
Chen, W., Zhou, Y., Zhi, X., Ma, T., Liu, H., Chen, B. W., Zheng, X., Xie, S., Zhao, B., Feng, X., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.035 · Cited by 77
Malhotra, M., Sekar, T. V., Ananta, J. S., Devulapally, R., Afjei, R., Babikir, H. A., Paulmurugan, R., & Massoud, T. F. (2018) · Oncotarget · doi:10.18632/oncotarget.25135 · Cited by 71
Bandey, I. N., Chiou, S.-H., Huang, A.-P., Tsai, J.-C., & Tu, P.-H. (2014) · Oncogene · doi:10.1038/onc.2014.92 · Cited by 69
Shi, S., Zhong, Z., Liu, J., Zhang, Z., Sun, X., & Gong, T. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0514-6 · Cited by 68
Cui, X., Sun, Y., Shen, M., Song, K., Yin, X., Di, W. J., & Duan, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b19183 · Cited by 66
MiR-568 inhibits the activation and function of CD4+ T cells and Treg cells by targeting NFAT5
Li, W., Kong, L., Li, J., Guo, Z., Xue, Q., Yang, T., Meng, Y., Jin, B., Wen, W., & Yang, A. (2013) · International Immunology · doi:10.1093/intimm/dxt065 · Cited by 63
Cao, M., Deng, X., Su, S., Zhang, F., Xiao, X., Hu, Q., Fu, Y., Yang, B. B., Wu, Y. F., Sheng, W., et al. (2013) · Nanoscale · doi:10.1039/c3nr04056a · Cited by 62
Zheng, X., Zhang, F., Zhao, Y., Zhang, J., Dawulieti, J., Pan, Y., Cui, L., Sun, M., Shao, D., Li, M., et al. (2018) · Theranostics · doi:10.7150/thno.25255 · Cited by 62
Parayath, N. N., Gandham, S. K., Leslie, F., & Amiji, M. M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.07.002 · Cited by 59
Cited by
RNA-based therapeutics: an overview and prospectus
Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05075-2 · Cited by 623
Emerging epigenetic modifications in renal fibrosis: From mechanisms to treatments
Suo, X., Ge, Q., Peng, L., Zhu, Q., Zhang, M., Cheng, X., Wang, F., Jin, J., Wang, J., & Meng, X. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.012 · Cited by 8
Metadata
- Authors
- Toden, S., Zumwalt, T. J., & Goel, A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 1875
- Issue
- 1
- Pages
- 188491
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W3112188147
- Cited by
- 327
- References
- 222
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.